Exploiting CRISPR/Cas9 to engineer precise segmental deletions in mouse embryonic stem cells

Rajula Elango1, Arvind Panday1, Nicholas A Willis1

  • 1Department of Medicine, Division of Hematology-Oncology and Cancer Research Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA.

STAR Protocols
|August 31, 2022
PubMed